Improve walking through Amazonian dance
- Trial ID
- NCT06967493
- Official Title
- "Amazonian Dance for Parkinson": a Protocol Study for a Randomized Clinical Trial on Motor and Non-motor Symptoms of People With Parkinson's.
- Goal
- Improve walking through Amazonian dance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Federal University of Rio Grande do Sul
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Parkinson Disease
- Interventions
- Amazonian Dance, Nordic Walking
Plain-Language Summary
Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
Locations
- Universidade Federal do Pará, Castanhal, Pennsylvania, Brazil
- Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Amazonian Dance. Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.